Rankings
▼
Calendar
PBYI Q2 2024 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
$311M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
-13.7% YoY
Gross Profit
$36M
77.4% margin
Operating Income
-$2M
-4.6% margin
Net Income
-$5M
-9.6% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+7.6%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
$1M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$205M
Total Liabilities
$156M
Stockholders' Equity
$49M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$55M
-13.7%
Gross Profit
$36M
$43M
-14.7%
Operating Income
-$2M
$5M
-144.5%
Net Income
-$5M
$2M
-313.0%
Revenue Segments
Product
$44M
94%
Royalty
$3M
6%
← FY 2024
All Quarters
Q3 2024 →